Cargando…

The Promise and Challenges of Developing miRNA-Based Therapeutics for Parkinson’s Disease

MicroRNAs (miRNAs) are small double-stranded RNAs that exert a fine-tuning sequence-specific regulation of cell transcriptome. While one unique miRNA regulates hundreds of mRNAs, each mRNA molecule is commonly regulated by various miRNAs that bind to complementary sequences at 3’-untranslated region...

Descripción completa

Detalles Bibliográficos
Autores principales:	Titze-de-Almeida, Simoneide S., Soto-Sánchez, Cristina, Fernandez, Eduardo, Koprich, James B., Brotchie, Jonathan M., Titze-de-Almeida, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226753/ https://www.ncbi.nlm.nih.gov/pubmed/32244357 http://dx.doi.org/10.3390/cells9040841

Ejemplares similares

Delivery of miRNA-Targeted Oligonucleotides in the Rat Striatum by Magnetofection with Neuromag(®)
por: Titze de Almeida, Simoneide Souza, et al.
Publicado: (2018)

Progress in circRNA-Targeted Therapy in Experimental Parkinson’s Disease
por: Titze-de-Almeida, Simoneide Souza, et al.
Publicado: (2023)

The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cells
por: Horst, Camila Hillesheim, et al.
Publicado: (2017)

Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide
por: Sales, Thais Torquato, et al.
Publicado: (2016)

Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque
por: Koprich, James B., et al.
Publicado: (2016)

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
por: Xavier, Mary-Ann, et al.
Publicado: (2021)

GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
por: Schneider, Jay S., et al.
Publicado: (2019)

miR-20a is upregulated in serum from domestic feline with PKD1 mutation
por: Scalon, Marcela Correa, et al.
Publicado: (2022)

Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
por: Koprich, James B., et al.
Publicado: (2011)

Subthalamic nucleus deep brain stimulation is neuroprotective in the A53T α‐synuclein Parkinson's disease rat model
por: Musacchio, Thomas, et al.
Publicado: (2017)

Persistent, new-onset symptoms and mental health complaints in Long COVID in a Brazilian cohort of non-hospitalized patients
por: Titze-de-Almeida, Ricardo, et al.
Publicado: (2022)

Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
por: Koprich, James B, et al.
Publicado: (2010)

miRNA therapeutics in cardiovascular diseases: promises and problems
por: Nouraee, Nazila, et al.
Publicado: (2015)

miRNA: A Promising Therapeutic Target in Cancer
por: Menon, Amrutha, et al.
Publicado: (2022)

Inflammasome inhibition protects dopaminergic neurons from α-synuclein pathology in a model of progressive Parkinson’s disease
por: Grotemeyer, Alexander, et al.
Publicado: (2023)

Challenge and promise: the role of miRNA for pathogenesis and progression of malignant melanoma
por: Essa, Salma, et al.
Publicado: (2010)

Exosome markers of LRRK2 kinase inhibition
por: Wang, Shijie, et al.
Publicado: (2020)

On the impact of non-symplecticity of space charge solvers
por: Titze, Malte
Publicado: (2016)

Approach to combined-function magnets via symplectic slicing
por: Titze, M
Publicado: (2016)

Study of the PS integer resonance
por: Titze, Malte
Publicado: (2019)

Space Charge Modeling at the Integer Resonance for the CERN PS and SPS
por: Titze, Malte
Publicado: (2020)

miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease
por: Elzayat, Emad M., et al.
Publicado: (2023)

Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction
por: Resende, Fernando F. B., et al.
Publicado: (2016)

miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
por: Zhou, Shan-shan, et al.
Publicado: (2018)

Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
por: Badr, Mohammad, et al.
Publicado: (2022)

How can vocal folds oscillate with a limited mucosal wave?
por: Titze, Ingo R.
Publicado: (2022)

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
por: Ip, Chi Wang, et al.
Publicado: (2017)

Role of miRNAs on the Pathophysiology of Cardiovascular Diseases
por: da Silva, Debora Cristina Pereira, et al.
Publicado: (2018)

MiRNA: Involvement of the MAPK Pathway in Ischemic Stroke. A Promising Therapeutic Target
por: Gugliandolo, Agnese, et al.
Publicado: (2021)

A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
por: Henrich, Martin Timo, et al.
Publicado: (2018)

Mild cognitive impairment in Parkinson’s disease: the challenge and the promise
por: Fernandez, Hubert H, et al.
Publicado: (2005)

Autophagy-regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)
por: Ma, Zhenwang, et al.
Publicado: (2023)

Physical activity recommendations for public health: development and policy context
por: Oja, Pekka, et al.
Publicado: (2011)

Antimicrobial Activity of a Phage Mixture and a Lactic Acid Bacterium against Staphylococcus aureus from Bovine Mastitis
por: Titze, Isabel, et al.
Publicado: (2020)

S04 Sports Club for Health (SCforH) approach: evidence on importance and examples of implementation activities
por: Pedišić, Željko, et al.
Publicado: (2022)

Living conditions of migrants in bavarian forensic psychiatry – acculturation, language competence and perceived ward climate
por: Titze, L., et al.
Publicado: (2021)

Monoamine Reuptake Inhibitors in Parkinson's Disease
por: Huot, Philippe, et al.
Publicado: (2015)

A Cervid Vocal Fold Model Suggests Greater Glottal Efficiency in Calling at High Frequencies
por: Titze, Ingo R., et al.
Publicado: (2010)

Pros and cons of a prion-like pathogenesis in Parkinson's disease
por: Hilker, Ruediger, et al.
Publicado: (2011)

Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
por: Wong, Jun Sheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c03g147rnqufq0rt87gpspemrr